Objective: To compare the concentrations of cytokines belonging to Th17 axis (interleukin (IL)-17 and IL-23) and Th1 axis (IL-12 and interferon (IFN)-g) in obese and lean women, and to investigate their relationships with the proinflammatory adipokine leptin, proinflammatory cytokine macrophage migration inhibitory factor (MIF) and anthropometric and metabolic parameters of obesity. Design: Cross-sectional study. 
Introduction
The increase in proinflammatory cytokine production has been recognized as an important marker of obesity and accompanying metabolic changes. Following the initial demonstration of the involvement of the principal proinflammatory cytokine tumor necrosis factor-a (TNFa) in obesity complications, 1 a large body of evidence has accumulated to support the role of a chronic low-grade inflammation in the pathogenesis of insulin resistance and the metabolic syndrome. 2, 3 Moreover, inflammation is involved in the pathogenesis of atherosclerosis, acute myocardial infarction and stroke, 4 while the increased concentration of inflammatory marker clusters with obesityrelated cardiovascular risk factors, such as dyslipidemia, glucose intolerance and type 2 diabetes. 5 Unlike 'classic' proinflammatory mediators, such as TNF-a, interleukin-6 (IL-6) and C-reactive protein, 2,3 the T-cellderived cytokines, such as interferon-g (IFN-g) and IL-17, have not been extensively investigated in obesity. IFN-g and IL-17 are mainly induced by monocyte/dendritic cell-derived IL-12 and IL-23, respectively, and have been implicated not only in the defense against cancer and infection, but also in pathology associated with the inflammatory response in autoimmunity. 6, 7 In addition to stimulating secretion of other proinflammatory cytokines, both IFN-g and IL-17 are involved in the induction of potentially harmful mediators of inflammation, such as free radical nitric oxide. 8 Moreover, some recent findings suggest that inflammation-related tissue damage in organ-specific autoimmunity could be associated with the IL-23/IL-17-dependent T-helper cell response (that is, Th17 response), rather than with the activity of IL-12/IFN-g cytokine axis as the main driving power behind the so-called Th1 response. 9 Although there are some data indicating that Th1 response might be reduced in malnourished and increased in obese children, [10] [11] [12] IL-23
and IL-17 have not been investigated as potential markers of the inflammatory syndrome in obesity. Their exploration in obesity is warranted by recent findings indicating that the proinflammatory adipokine leptin and the proinflammatory cytokine macrophage migration inhibitory factor (MIF), both known to be increased in obese humans, 13-17 might stimulate IL-17 production in T cells. 18, 19 The aim of this study was to investigate the activity of IL-23/IL-17 and IL-12/IFN-g cytokine axis in obesity, as well as their relationship with the proinflammatory mediators MIF and leptin. The association between cytokine levels and the major anthropometric and metabolic markers of obesity was also explored.
Materials and methods

Subjects
The study group consisted of 26 obese women, whereas the control group consisted of 20 lean volunteers. Inclusion criteria were as follows: women in reproductive period, no smoking habits, no alcohol consumption, blood pressure 130/80 mm Hg or less, normal glucose tolerance evaluated by a standard glucose tolerance test, normal thyroid function and cortisol secretion, regular menses, no regular physical exercise. All obese subjects included in the study were diagnosed as having simple obesity without additional disease. Twenty healthy subjects who were matched with the study group for age and sex served as controls. The study was conducted after obtaining informed consent from all the subjects. The study was approved by the Ethics Committee of the School of Medicine, Belgrade. 
Cytokine and hormone measurements
Insulin was determined by radioimmunoassay kit (Inep Zemun, Belgrade, Serbia). The lower limit of detection for insulin was 0.6 IU ml
À1
, whereas the intra-assay coefficients of variation were 3.84% for the concentration 15.5 IU ml À1 , 2.51% for the concentration 31.7 IU ml À1 and 5.25% for the concentration 117.0 IU ml
. Total leptin was determined by radioimmunoassay kit (Linco Research, St Charles, MO, USA) with an intra-assay coefficient of variation of less than 6%. The minimum detectable concentration is estimated to be 1 ng ml À1 . All the above data were stated by the manufac- ). The intra-assay precision data for all cytokines were obtained in our laboratory.
Statistical analysis
Statistical analysis was carried out using the Statistica software package (version 6.1; Statsoft Inc., Tulsa, OK, USA). For a desired value of Po0.05 and 80% power to detect an actual difference, a sample size of 20 per group was considered satisfactory. All numeric variables were tested for normality of distribution using the Kolmogorov-Smirnov test and, if necessary, were subjected to logarithmic transformation before applying parametric tests (MIF, IL-12 and IFN-g). Unpaired t-test was used to test the significance of the difference in parameter values between obese and lean subjects, whereas the Mann-Whitney test was used for data that did not conform to normality after logarithmic transformation (IL-23). The differences in frequency of cytokine detection in the two groups were evaluated by w 2 test. Pearson correlation analysis or Spearman correlation (for IL-23) was employed to assess the correlation between different parameters. As multiple tests were performed (6 involving all samples and 15 on samples from obese IL-23/IL-17 axis in obese women M Sumarac-Dumanovic et al women), the obtained P-values that were lower than 0.05 were corrected using the Holm-Bonferroni step-down approach. The corrected P-values (P c ) of less than 0.05 were considered significant.
Results
Blood concentrations of IL-17 and IL-23 are increased in obese women The main clinical parameters assessed in the study are presented in Table 1 . In comparison with lean subjects, obese patients presented with increased BMI, WC and HOMA index of insulin resistance. Leptin, MIF and IL-12 were detected in all samples tested. IL-17, IL-23 and IFN-g were more frequently detected in overweight (100, 42 and 77%, respectively) than in lean subjects (90, 15 and 65%, respectively), but the difference did not reach the level of statistical significance (P40.05). The plasma levels of leptin, MIF, IL-17 and IL-23 were significantly higher in obese compared with lean women (Figures 1a-d) . On the other hand, the levels of IL-12 and IFN-g did not significantly differ between obese and lean subjects (Figures 1e and f) .
Correlation between IL-17 and IL-23 in obese women
To assess the possible associations between the different cytokines that were increased in obese women, we next performed correlation analyses in the obese women group. The only association observed was a positive correlation between concentrations of IL-17 and IL-23 (r s ¼ 0.530), which was at the border of statistical significance after the Holm-Bonferroni correction (P ¼ 0.005, P c ¼ 0.065) (Figure 2 
Discussion
We here demonstrate for the first time that blood concentrations of important proinflammatory cytokines IL-17 and IL-23 are increased in obese women. Our data also indicate that the increase in IL-17 and IL-23 in obesity is independent of the production of the proinflammatory mediators leptin and MIF and not directly associated with the increase in adipose tissue mass or insulin resistance. While introducing IL-17 and IL-23 as additional markers of the inflammatory syndrome that accompanies obesity, our results also confirm earlier reports on the increase in leptin and MIF levels in obese humans. [13] [14] [15] [16] [17] Both leptin and MIF are well known for their ability to stimulate secretion of various proinflammatory mediators in different experimental systems, 17,20 the latter being proposed to function as a master controller of systemic inflammation. 20 Moreover, some recent studies indicate that leptin and MIF might also stimulate the expression of IL-17 in human and mouse mononuclear cells, respectively. 18, 19 Our results, however, argue against the possibility that such a link might be operative in human obesity, as no correlation was observed between the levels of IL-17 or IL-23 and those of leptin or MIF in obese women. On the other hand, IL-17 showed a clear tendency toward positive correlation with IL-23 in obese subjects, which is consistent with the well-known role of IL-23 in inducing IL-17 secretion in T lymphocytes and other cell types. 21, 22 Therefore, it seems plausible to assume that IL-23, but not leptin or MIF, contributed to the increase in IL-17 production in obese women.
There is a question about the possible cellular source of IL-17 and IL-23 in obese patients. Adipose tissue is an important source of proinflammatory mediators, and adipocyte-secreted leptin is the most prominent example. 17 The adipose origin of leptin is accordingly reflected in a positive correlation between its blood levels and BMI or WC as an indicator of abdominal fat content, 17 which was confirmed in the present study. In addition, it has been proposed that the production of MIF in obesity could be partially attributed IL-23/IL-17 axis in obese women M Sumarac-Dumanovic et al to adipocytes and/or non-fat cells present in adipose tissue. 23, 24 However, although IL-17F is preferentially expressed in adipose tissue, 25 there are no studies confirming that adipose tissue contains IL-17A, a prototype IL-17 family member that was measured in the present study. On the other hand, human adipose tissue-derived macrophages express IL-23 among other proinflammatory cytokines, 26 and macrophage infiltration into omental fat is augmented IL-23/IL-17 axis in obese women M Sumarac-Dumanovic et al in obesity. [27] [28] [29] Moreover, it has been shown that T lymphocytes, which represent the main source of IL-17A, 30, 31 accumulate to a greater extent in adipose tissue of obese animals and humans, as compared with lean controls. [32] [33] [34] It therefore seems conceivable that the increased accumulation of inflammatory macrophages and T cells in adipose tissue might contribute to the production of IL-23 and IL-17 in obese women. Nevertheless, the lack of correlation between IL-23 or IL-17 and central obesity markers (BMI and particularly WC) in obese subjects, though not directly contradicting this hypothesis, suggests that the accumulation of IL-23/IL-17-producing cells in adipose tissue might not increase in proportion with the buildup of abdominal fat. Although it is also possible that blood mononuclear cells or some other cell type, rather than leukocytes infiltrating the adipose tissue, could be the main source of IL-17 and IL-23 in obese subjects, additional research is required to test these assumptions. While neither IL-17 nor IL-23 displayed a positive correlation with insulin resistance in obese patients, the observed trend toward negative correlation between IL-23 and HOMA index requires further attention. Nevertheless, these findings do not support the pathogenic role of IL-23/IL-17 cytokine axis in the metabolic disturbances associated with obesity. On the other hand, it is possible that IL-17 could promote low-grade inflammation in obese patients, as it is capable of inducing other proinflammatory mediators such as TNF, IL-1, IL-6 and nitric oxide in various cell types. 8 It has recently been proposed that IL-17 upregulation in vascular endothelial and smooth muscle cells could promote proinflammatory functional and phenotypic alterations in blood vessels contributing to the development of atherothrombotic vascular disease. 35 Accordingly, IL-17 expression in blood vessels seems to increase several fold in proatherogenic conditions, such as aging. 36 Moreover, the proinflammatory shift in cytokine profile during the development of ischemic coronary disease is characterized by the increase in numbers of IL-17-producing T cells and IL-17 blood levels. 37, 38 Therefore, the possible involvement of IL-23/IL-17 proinflammatory cytokine axis in cardiovascular complications related to obesity seems worthy of investigation. In addition to IL-23 and IL-17, the activity of another important proinflammatory cytokine axis, comprising IFN-g and its inducer IL-12, was compared in obese and lean women. Although our study may be under-powered to detect differences in IFN-g or IL-12 because of the relatively low number of subjects, our data do not indicate that these Th1 cytokines are increased in obese women. This seems to be in contrast with the findings showing that the systemic immune response in obese children is skewed to Th1 profile, as demonstrated by an increase in numbers of IFN-gsecreting helper T cells. 10 In addition to the possibility that the increase in Th1 response in obesity might be age-and/or gender-related, it should be noted that it can also occur through downregulation of Th1 counter-regulatory Th2 response characterized by IL-4 secretion, 12 which was not assessed in our study.
In conclusion, the activity of IL-23/IL-17 cytokine axis seems to be increased in obese women independently of proinflammatory mediators MIF and leptin. Although our results do not indicate a direct pathogenic role of IL-17 and IL-23 in metabolic disturbances that accompany obesity, additional studies are required to explore the possible clinical implications of their increase in obese humans.
